{"transactions":[{"id":703015,"issuer":{"id":5494,"kind":"organization","name":"Scribe Therapeutics, Inc."},"owners":[{"id":28562,"kind":"person","name":"Bleharski Joshua","position":1,"cik":"0002075052","reported_name":"Bleharski Joshua","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-28T01:22:06.000Z","date":"2026-07-23","kind":"grant","planned":false,"acquired":true,"shares":14725,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest as to 1/3 of the total shares on each of July 23, 2027, July 23, 2028 and July 23, 2029, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":14725,"derivative":{"exercise_price":15,"expiration_date":"2036-07-22","underlying":"Common Stock","underlying_shares":14725},"source":{"system":"sec-edgar","filing":"0002075052-26-000004","document":"form4-07282026_010701.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853921/000207505226000004/form4-07282026_010701.xml","form_type":"4"}},{"id":924471,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":28562,"kind":"person","name":"Bleharski Joshua","position":1,"cik":"0002075052","reported_name":"Bleharski Joshua","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-03T01:05:22.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":170000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on the first anniversary measured from January 1, 2026 (the \"Vesting Commencement Date\"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":170000,"derivative":{"exercise_price":32.19,"expiration_date":"2036-01-30","underlying":"Common Stock","underlying_shares":170000},"source":{"system":"sec-edgar","filing":"0001610717-26-000038","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071726000038/form4.xml","form_type":"4"}}]}